INTERCEPT PHARMACEUTICALS IN's ticker is and the CUSIP is 45845PAA6. A total of 21 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $3,515,000 | +22.6% | 3,847,000 | +26.3% | 0.00% | – |
| Q4 2021 | $2,868,000 | +5.0% | 3,045,000 | 0.0% | 0.00% | – |
| Q3 2021 | $2,731,000 | -92.5% | 3,045,000 | -92.6% | 0.00% | -100.0% |
| Q2 2021 | $36,647,000 | +2024.5% | 40,877,000 | +1828.2% | 0.00% | – |
| Q1 2021 | $1,725,000 | -5.6% | 2,120,000 | -10.5% | 0.00% | – |
| Q4 2020 | $1,827,000 | +65.9% | 2,370,000 | +73.0% | 0.00% | – |
| Q3 2020 | $1,101,000 | +6.8% | 1,370,000 | 0.0% | 0.00% | – |
| Q2 2020 | $1,031,000 | -5.9% | 1,370,000 | 0.0% | 0.00% | – |
| Q1 2020 | $1,096,000 | -26.0% | 1,370,000 | -6.8% | 0.00% | – |
| Q4 2019 | $1,482,000 | +9.8% | 1,470,000 | -6.4% | 0.00% | – |
| Q3 2019 | $1,350,000 | +23.6% | 1,570,000 | +28.2% | 0.00% | – |
| Q2 2019 | $1,092,000 | -9.9% | 1,225,000 | 0.0% | 0.00% | – |
| Q1 2019 | $1,212,000 | +16.9% | 1,225,000 | +8.9% | 0.00% | – |
| Q4 2018 | $1,037,000 | +2.6% | 1,125,000 | +12.5% | 0.00% | – |
| Q3 2018 | $1,011,000 | +53.9% | 1,000,000 | +33.3% | 0.00% | – |
| Q2 2018 | $657,000 | -38.1% | 750,000 | -43.4% | 0.00% | – |
| Q1 2018 | $1,062,000 | -5.1% | 1,325,000 | -5.9% | 0.00% | – |
| Q4 2017 | $1,119,000 | +2.8% | 1,408,000 | 0.0% | 0.00% | – |
| Q3 2017 | $1,088,000 | +76.6% | 1,408,000 | +122.4% | 0.00% | – |
| Q2 2017 | $616,000 | +39.1% | 633,000 | +33.3% | 0.00% | – |
| Q1 2017 | $443,000 | – | 475,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|